KL and metabolic dysfunction-associated steatotic liver disease: Given the observed negative association between α-Klotho and both CVD risk and cardiometabolic comorbidities, we conducted mediation analyses to explore whether metabolic conditions—T2DM, obesity, CKD, and NAFLD—serve as intermediaries in this relationship.